Ventolin hfa and Cyclophosphamide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ventolin hfa (albuterol sulfate) and Cyclophosphamide (cyclophosphamide). Common drug interactions include alopecia among females and hypotension among males.

The phase IV clinical study analyzes what interactions people have when they take Ventolin hfa and Cyclophosphamide. It is created by eHealthMe based on reports of 49 people who take the same drugs from the FDA, and is updated regularly.

What is Ventolin hfa?

Ventolin hfa has active ingredients of albuterol sulfate. It is often used in asthma. eHealthMe is studying from 40,061 Ventolin hfa users. Check the latest studies of Ventolin hfa.

What is Cyclophosphamide?

Cyclophosphamide has active ingredients of cyclophosphamide. It is often used in multiple myeloma. eHealthMe is studying from 185,240 Cyclophosphamide users. Check the latest studies of Cyclophosphamide.



On Jul, 18, 2026

49 people who take Ventolin hfa and Cyclophosphamide together, and have interactions are studied.

Ventolin hfa and Cyclophosphamide drug interactions.

What are the common drug interactions of Ventolin Hfa and Cyclophosphamide, by gender? *:

female:

  1. Alopecia (absence of hair from areas of the body)
  2. Hair disorder
  3. Cough
  4. Hair colour changes
  5. Systemic mycosis (fungal infections of the body)
  6. Anxiety
  7. Constipation
  8. Dizziness
  9. Dysarthria (speech disorder)
  10. Febrile neutropenia (fever with reduced white blood cells)

male:

  1. Hypotension (abnormally low blood pressure)
  2. Pyrexia (fever)
  3. Drug hypersensitivity
  4. Encephalopathy (functioning of the brain is affected by some agent or condition)
  5. Haemorrhage (bleeding)
  6. Hypoxia (low oxygen in tissues)
  7. Lipoma (a growth of fatty tissue that slowly develops just under your skin)
  8. Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)
  9. Pain in extremity
  10. Pneumonia parainfluenzae viral (parainfluenza virus infections can cause severe pneumonia)

What are the common drug interactions of Ventolin Hfa and Cyclophosphamide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Alopecia (absence of hair from areas of the body)
  2. Hair colour changes
  3. Hair disorder

40-49:

  1. Alopecia (absence of hair from areas of the body)
  2. Psychological trauma

50-59:

  1. Alopecia (absence of hair from areas of the body)
  2. Hair disorder
  3. Febrile neutropenia (fever with reduced white blood cells)
  4. Hair colour changes
  5. Anxiety
  6. Arthralgia (joint pain)
  7. Blood pressure increased
  8. Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
  9. Chronic kidney disease
  10. Cough

60+:

  1. Hypotension (abnormally low blood pressure)
  2. Dizziness
  3. Drug hypersensitivity
  4. Encephalopathy (functioning of the brain is affected by some agent or condition)
  5. Fatigue (feeling of tiredness)
  6. Haemorrhage (bleeding)
  7. Hypoxia (low oxygen in tissues)
  8. Lipoma (a growth of fatty tissue that slowly develops just under your skin)
  9. Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)
  10. Pain in extremity

What are the existing conditions these people have? *

  1. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 14 people, 28.57%
  2. Pain: 10 people, 20.41%
  3. Bone Marrow Conditioning Regimen: 10 people, 20.41%
  4. Constipation: 10 people, 20.41%
  5. Indigestion: 9 people, 18.37%
  6. Dyspnea (difficult or laboured breathing): 8 people, 16.33%
  7. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 8 people, 16.33%
  8. High Blood Pressure: 8 people, 16.33%
  9. Flatulence (flatus expelled through the anus): 7 people, 14.29%
  10. Dry Eyes (lack of adequate tears): 7 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Ventolin hfa and Cyclophosphamide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ventolin hfa and Cyclophosphamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ventolin hfa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cyclophosphamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ventolin hfa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cyclophosphamide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on albuterol sulfate and cyclophosphamide (the active ingredients of Ventolin hfa and Cyclophosphamide, respectively), and Ventolin hfa and Cyclophosphamide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: